School of Medicine


Showing 1-7 of 7 Results

  • Anuja Anand Sathe

    Anuja Anand Sathe

    Postdoctoral Research Fellow, Oncology

    Current Research and Scholarly Interests I am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell RNA sequencing.

  • Michael Spinner

    Michael Spinner

    Postdoctoral Medical Fellow, Oncology

    Bio Dr. Michael Spinner received his undergraduate degree in music (classical guitar performance) from Emory University, attended medical school at Vanderbilt, and completed his internal medicine residency at Stanford before continuing his fellowship training in hematology/oncology at Stanford. During medical school, Michael participated in the NIH Medical Research Scholars Program, working with Dr. Steven Holland on characterizing a primary immunodeficiency and bone marrow failure disorder resulting from germline GATA2 mutations (GATA2 deficiency). This work led to a new clinical protocol to better understand the natural history of GATA2 deficiency and a plenary paper in Blood, which has been cited over 300 times. At Stanford under the mentorship of Drs. Ranjana Advani, Robert Lowsky, and Peter Greenberg, Michael's clinical and research interests have focused on therapeutic clinical trials for patients with hematologic malignancies, including targeted therapies, immunotherapies, cellular therapies, and novel approaches to hematopoietic cell transplantation. After completing fellowship, Michael plans to pursue a career in academic medicine as an active clinician and clinical/translational investigator specializing in lymphoma. Outside of medicine, Michael is an avid classical guitarist with a passion for classical music and jazz.

  • Chloe B. Steen

    Chloe B. Steen

    Postdoctoral Research Fellow, Oncology

    Bio I am computational biologist and a joint postdoctoral scholar in the labs of Drs. Ash Alizadeh and Aaron Newman. My interest lies in better understanding the cellular heterogeneity of tumors.

Latest information on COVID-19